INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
MD
McWilliams Vicki D.Director
TPHTri Pointe Homes, Inc.
Grant or award
A$175K
3,734 sh
Apr 17, 2026Apr 20, 2026
Page 936 of 1737
← PrevNext →
traded Apr 17, 2026
+3d
SEC Form 4

Evidence

16
BJ
Bunting JohnSEVP, Chief Corp. Inst.Bnk Ofr
HOPEHOPE BANCORP INC
Tax withholding
F$63K
5,167 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

16
GK
Grahl Robert KentDirector
TPHTri Pointe Homes, Inc.
Grant or award
A$175K
3,734 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

16
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$956K
36.9K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

16
DR
Dillard Robert REVP & Chief Financial Officer
KBHKB HOME
Tax withholding
F$125K
2,297 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

15
CC
Chang Stephen ChunpingDirector, Chief Executive Officer
AOSLALPHA & OMEGA SEMICONDUCTOR Ltd
Open-market sale · 10b5-1 plan
SELL$49K
1,492 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

15
LN
Little NicholasCHIEF OPERATING OFFICER
DXPEDXP ENTERPRISES INC
Tax withholding
F$808K
5,821 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

15
DH
Davis Cynthia HDirector
CIACITIZENS, INC.
Small acquisition
L$299
55 sh
Apr 7, 2026Apr 20, 2026
traded Apr 7, 2026
+13dSEC Form 4

Evidence

15
DA
Dearborn Joel Alan JRCOO, International
WEXWEX Inc.
Open-market sale · 10b5-1 plan
SELL$613K
3,500 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

14
DN
Debbi NirDirector, President
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$249K
7,191 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

14
HJ
Haas Alesia JChief Financial Officer
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$2.00M
10.0K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
2,437 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

13
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Option exercise
M—
335 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
72.9K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

13
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
2,813 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

13
BP
Benny Purushotam PatelDirector
LECOLINCOLN ELECTRIC HOLDINGS INC
Grant or award
A—
688 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

13
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Option exercise
M—
305 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

13
WT
West TonySee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,910 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
1,000 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
346.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

13
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
2,001 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
2,531 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

13
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Option exercise
M—
584 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

13
RN
Rogers Mark NEVP & General Counsel
AMKRAMKOR TECHNOLOGY, INC.
Option exercise
M—
5,000 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
WE
Williams ElworthSEVP, Chief Comm Banking Ofcr
HOPEHOPE BANCORP INC
Tax withholding
F$34K
2,799 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
WO
White Timothy OgdenPresident
ALMRAlamar Biosciences, Inc.
Grant or award
A—
37.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

13
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
4,042 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
667 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
RN
Rogers Mark NEVP & General Counsel
AMKRAMKOR TECHNOLOGY, INC.
Option exercise
M$37K
5,000 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
500 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,547 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Grant or award
A—
37.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

13
AT
Abraham ThomasPRESIDENT, SBC
BYBYLINE BANCORP, INC.
Grant or award
A—
2,406 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

13
EL
Etzkorn LillianEVP, CFO
LCIILCI INDUSTRIES
Tax withholding
F—
499 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

13
GP
Goris Patrick P.Director
LECOLINCOLN ELECTRIC HOLDINGS INC
Grant or award
A—
688 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

12
WO
White Timothy OgdenPresident
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
16.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$354K
15.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
27.7K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
266.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence